CD8A and neoplasm: anti-tumor (blocks the immune suppression by myeloid-derived suppressor cells and reduces tumor burden), antiviral (inhibits the development of dengue and hepatitis B virus infection), antifungal (particularly, against Aspergillus fumigatus), immunomodulation (stimulates CD4+ and CD8+ T cells), anti-coagulation.